Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tempus Pro Patient Monitor

K-Number: K201746 · 2020-09-18

Decision Date2020-09-18
Product CodeMHX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Tempus Pro Patient Monitor is a medical device manufactured by Remote Diagnostic Technologies Limited. It received FDA 510(k) clearance on 2020-09-18 under approval number K201746. The device is classified under product code MHX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tempus Pro Patient Monitor?

Tempus Pro Patient Monitor is a medical device that received FDA 510(k) clearance on 2020-09-18. It is manufactured by Remote Diagnostic Technologies Limited. The 510(k) number is K201746.

When was Tempus Pro Patient Monitor approved by the FDA?

Tempus Pro Patient Monitor received FDA 510(k) clearance on 2020-09-18, under approval number K201746.

What company makes Tempus Pro Patient Monitor?

Tempus Pro Patient Monitor is manufactured by Remote Diagnostic Technologies Limited.

What is the FDA product code for Tempus Pro Patient Monitor?

The FDA product code for Tempus Pro Patient Monitor is MHX.

Related Clinical Trials

Related Devices (Code: MHX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.